No abstract available
Keywords:
Bisphosphonate; Denosumab; Medication-related osteonecrosis of the jaw; Prosthodontic treatment; TRAP-positive mononuclear cells.
MeSH terms
-
Animals
-
Antibodies, Monoclonal / adverse effects*
-
Bisphosphonate-Associated Osteonecrosis of the Jaw / etiology*
-
Bone Density Conservation Agents / adverse effects*
-
Bone Marrow Cells / metabolism
-
Denosumab / adverse effects*
-
Diphosphonates / adverse effects*
-
Humans
-
Jaw*
-
Macrophages
-
Mice
-
Monocytes
-
Prosthodontics / methods*
-
Prosthodontics / trends*
-
RANK Ligand / immunology
-
Tartrate-Resistant Acid Phosphatase / metabolism
Substances
-
Antibodies, Monoclonal
-
Bone Density Conservation Agents
-
Diphosphonates
-
RANK Ligand
-
Denosumab
-
ACP5 protein, human
-
Tartrate-Resistant Acid Phosphatase